208 results on '"Yao, Dong-ming"'
Search Results
2. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
3. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia
4. Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis
5. Detection of NPM1 Mutations in Acute Myeloid Leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application
6. Effects of Powdery Mildew on 1000-Kernel Weight, Crude Protein Content and Yield of Winter Wheat in Three Consecutive Growing Seasons
7. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome
8. Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia
9. Aberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome
10. CEBPA methylation and mutation in myelodysplastic syndrome
11. Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia
12. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia
13. Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia
14. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis
15. Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia
16. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
17. Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia
18. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome
19. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome
20. IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
21. Methylation status of fragile histidine triad ( FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome
22. Aberrant hypomethylation of DDX43 promoter in myelodysplastic syndrome
23. Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome
24. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis
25. Overexpression of lncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia
26. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome
27. Hypermethylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter: a poor prognostic factor in myelodysplastic syndrome: 415
28. GTPase regulator associated with the focal adhesion kinase (GRAF) was silenced in myeloid malignancies: 409
29. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia
30. The relationship between FHIT aberrant methylation and survival in myelodyplastic syndrome: 46
31. Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia.
32. MOESM1 of Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
33. Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
34. Hypomethylation of MIR‐378 5’‐flanking region predicts poor survival in young patients with myelodysplastic syndrome
35. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
36. GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies
37. Methylation status of DDIT3 gene in Chronic Myeloid Leukemia
38. SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
39. Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia
40. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia
41. Reduced Protocadherin17 Expression in Leukemia Stem Cells: The Clinical and Biological Effect in Acute Myeloid Leukemia
42. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome
43. KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
44. Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
45. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia
46. GPX3 promoter is methylated in chronic myeloid leukemia
47. GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia
48. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia
49. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia
50. SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.